glp 1 efficacy comparison Comparative and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials Comparative effectiveness of GLP-1 receptor

Description

Because MAO inhibitors target not only serotonin but also other monoamines like catecholamine hormones [230], one should be cautious to apply them to treat metabolic disorders

[DOI] [Google Scholar] 89.Packer M, et al

They are mostly used to treat obesity and type 2 diabetes

doi:10.1016/j.biomaterials.2019.119491 2022 The Author(s)

Follow-Up: Review within 12 months, a 3-hour refresher session and updated self-management plan

For the 40.7 percent of patients who persisted with their medication for a full year, those taking semaglutide for obesity lost an average of 12.9 percent of their body weight